Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Westlake Chemical Partners (WLKP) Liabilities and Shareholders Equity (2016 - 2025)

Westlake Chemical Partners' Liabilities and Shareholders Equity history spans 13 years, with the latest figure at $1.3 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 2.44% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $5.2 billion, up 0.79%, while the annual FY2025 figure was $1.3 billion, 2.44% down from the prior year.
  • Liabilities and Shareholders Equity reached $1.3 billion in Q4 2025 per WLKP's latest filing, down from $1.3 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.5 billion in Q4 2021 to a low of $1.3 billion in Q4 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $1.4 billion, with a median of $1.3 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: rose 9.16% in 2021, then decreased 8.65% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.5 billion in 2021, then decreased by 7.34% to $1.4 billion in 2022, then fell by 4.02% to $1.3 billion in 2023, then decreased by 2.19% to $1.3 billion in 2024, then decreased by 2.44% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for WLKP's Liabilities and Shareholders Equity are $1.3 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025).